Conmed (CNMD) Tops Q1 EPS by 3c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $47.20 -1.01%
EPS Growth %: -7.4%
Financial Fact:
Cost of sales: 83.58M
Today's EPS Names:
OMID, SICP, SCKT, More
EPS Growth %: -7.4%
Financial Fact:
Cost of sales: 83.58M
Today's EPS Names:
OMID, SICP, SCKT, More
Join SI Premium – FREE
Conmed (NASDAQ: CNMD) reported Q1 EPS of $0.57, $0.03 better than the analyst estimate of $0.54. Revenue for the quarter came in at $218.4 million versus the consensus estimate of $212.99 million.
GUIDANCE:
Conmed sees FY2019 EPS of $2.47-$2.52, from $2.42-$2.47 and the consensus of $2.45.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PPG Industries (PPG) Tops Q3 EPS by 12c ; Offers Guidance
- Beta Bionics, Inc. (BBNX) Misses Q3 EPS by 20c
- Enphase Energy (ENPH) Misses Q3 EPS by 10c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
